About Us
Refocus Group, Inc. is a medical device company involved in researching and developing innovative treatments for human vision disorders, particularly for the treatment of presbyopia. Our VisAbility™ Micro Insert System—the world’s first binocular presbyopic treatment that works outside the visual axis—is currently in clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.
Click on the links below to read more about our company and our mission.
